was provided by Grubiodeq Lab (Biotechnology Group, University of Cordoba), to which testing was carried out to evaluate probiotic capacity thereof.
under oxygen-limited fermentative conditions.
The Saccharomyces cerevisiae
strains 97, 222, and 225, tested in 50% (w [v.
Se utilizo la cepa Saccharomyces cerevisiae
var boulardii procedente del cepario de la Unidad de Investigacion en Microbiologia Ambiental (UIMA)--Seccion Micologia.
Bioethanol can be produced by many kinds of microorganisms, of which Saccharomyces cerevisiae
is the most employed species for industrial production (Widiastuti et al.
is the main species of yeast employed for ethanol production at industrial level since this microorganism is easy to handle, shows no high nutritional needs, can easily withstand 10-15 % ethanol (10).
However, according to other authors, Saccharomyces cerevisiae
is undetectable on grapes [9,28].
They then investigated engineering the yeast Saccharomyces cerevisiae
to express a gene that allowed it to convert the nitrile-containing chemical cyanamide into urea, from which it could obtain nitrogen.
Feed conversion ratio: The FCR showed improvement in broilers fed diets containing yeast, Toyocerine(r) and mixture of both (Saccharomyces cerevisiae
+ Toyocerine(r)) compared to birds fed diets without probiotic supplementation (Table 2).
one of the best models of unicellular eukaryotic system to study oxidative stress.
This updated edition of the Cold Spring Harbor Laboratory course manual provides eleven teaching experiments and protocols, and recipes for the standard techniques and reagents used in the study of yeast Saccharomyces cerevisiae
as a model of multiple cellular processes.
For instance, supplementing beef cattle with Saccharomyces cerevisiae
could raise the live weight by 7.
In fact, assays using the eukaryotic yeast Saccharomyces cerevisiae
have been employed to evaluate the antioxidant activity of flavonoids and vegetable extracts (Soares et al.
Based on the findings of a first clinical trial, which were recently published in the journal Digestive and Liver Disease, Health Canada has granted Lesaffre Human Care a new condition-specific claim for ibSium, the company's unique strain of Saccharomyces cerevisiae
Growth and the Ability of Pseudomoanas sp and Bacillus sp to be Phosphorus Solubilizers for Industrial Usage